TP53 and carcinoma: TP53 mutations were also more frequent in poorly differentiated (G3) carcinomas (p = 0.016) but were not associated with age, tumor size (cT), nodal stage (cN), histological subtype, or PIK3CA mutational status (p > 0.05 each).